Optimal liver allocation for hepatocellular carcinoma: hurry up AND wait, but which one when?

Am J Transplant. 2014 Jul;14(7):1479-80. doi: 10.1111/ajt.12773. Epub 2014 Jun 5.

Authors

M Schwartz¹, S Florman

Affiliation

¹ Icahn School of Medicine at Mount Sinai, Recanati/Miller Transplantation Institute, New York, NY.

PMID: 24903890
DOI: 10.1111/ajt.12773

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Hepatocellular / pathology*
Female
Humans
Liver Neoplasms / pathology*
Liver Transplantation / adverse effects*
Male
Neoplasm Recurrence, Local / diagnosis*
Patient Selection*
Transplant Recipients*
Waiting Lists*